Genegrafts Ltd.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 75.0

EPO Patents = 1

Forward Citations = 4

Loading Chart...

6 inventors (with patents filed for the assignee):

Yair Feld (4 out of 15 patents)

Lior Gepstein (4 out of 4 patents)

Shimon Marom (4 out of 4 patents)

4. Tal Bresler (1 out of 1 patent)

5. Reem Miari (1 out of 1 patent)

6. Meira Frank (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 8101736 - Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same (2012-01-24),

2. 8007779 - Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues (2011-08-30),

3. 7491385 - Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues (2009-02-17),

4. 7294333 - Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues (2007-11-13),

Company Overview

Genegrafts Ltd. is a biotechnology company specializing in regenerative medicine. We focus on developing innovative grafting solutions to promote healing and tissue regeneration. Our mission is to improve patient outcomes through cutting-edge technologies and personalized treatments. With a strong commitment to research and development, we strive to revolutionize the field of regenerative medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#52 in Haifa

#1,417 in Israel

Haifa, Israel

Genegrafts Ltd.

Forward Citations = 4

6 inventors:

Yair Feld (4 out of 15 patents)

Lior Gepstein (4 out of 4 patents)

Shimon Marom (4 out of 4 patents)

4. Tal Bresler (1 out of 1 patent)

5. Reem Miari (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genegrafts Ltd.. Retrieved from https://idiyas.com/company/genegrafts

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]